What is UroGen Pharma's earnings yield?

UroGen Pharma (URGN) reported earnings yield of -15.2% in Q1 2026.

How has UroGen Pharma's earnings yield changed year-over-year?

UroGen Pharma's earnings yield increased by 43.9% year-over-year, from -27.2% to -15.2%.

What is the long-term trend for UroGen Pharma's earnings yield?

Over 5 years (2020 to 2025), UroGen Pharma's earnings yield has grown at a -15.1% compound annual growth rate (CAGR), from -31.8% to -14%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

UroGen Pharma URGN Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

PfizerPFE

6.8%—

Johnson & JohnsonJNJ

3.6%-1.9pp

Merck & Co.MRK

3%-4.7pp

ImmunityBio, Inc.IBRX

-10.8%-2.6pp

Tyra Biosciences, Inc.TYRA

-6.4%-2.6pp

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Calculated from UroGen Pharma’s reported figures.

net income/market cap=-15.2%

Based on trailing twelve months.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's earnings yield?: UroGen Pharma (URGN) reported earnings yield of -15.2% in Q1 2026.
How has UroGen Pharma's earnings yield changed year-over-year?: UroGen Pharma's earnings yield increased by 43.9% year-over-year, from -27.2% to -15.2%.
What is the long-term trend for UroGen Pharma's earnings yield?: Over 5 years (2020 to 2025), UroGen Pharma's earnings yield has grown at a -15.1% compound annual growth rate (CAGR), from -31.8% to -14%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.